APA (7th ed.) Citation

Pavlov, A. I., Kirillov, S. M., Ponomarenko, D. S., Havanshanov, A. K., Fadina, J. V., Bobkova, I. V., . . . Morozova, M. A. (2016). Efficacy and safety of сepeginterferon alfa-2b in double treatment regimen (cepeginterferon alfa-2b and ribavirin) of antiviral therapy in patients with chronic hepatitis C genotypes 2 and 3. Experience of real clinical practice. Journal Infectology.

Chicago Style (17th ed.) Citation

Pavlov, A. I., et al. Efficacy and Safety of сepeginterferon Alfa-2b in Double Treatment Regimen (cepeginterferon Alfa-2b and Ribavirin) of Antiviral Therapy in Patients with Chronic Hepatitis C Genotypes 2 and 3. Experience of Real Clinical Practice. Journal Infectology, 2016.

MLA (9th ed.) Citation

Pavlov, A. I., et al. Efficacy and Safety of сepeginterferon Alfa-2b in Double Treatment Regimen (cepeginterferon Alfa-2b and Ribavirin) of Antiviral Therapy in Patients with Chronic Hepatitis C Genotypes 2 and 3. Experience of Real Clinical Practice. Journal Infectology, 2016.